ISSN: 0312-5963

Journal Home

Journal Guideline

Clinical Pharmacokinetics Q1 Unclaimed

Adis International Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacokinetics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 184. It has a price of 3290 €. It has an SJR impact factor of 1,125 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,125.

Clinical Pharmacokinetics focuses its scope in these topics and keywords: pharmacokinetics, pharmacodynamics, subjects, metastatic, lmethyltetrahydrofolateclinical, intramuscular, interactions, ii, ideal, healthy, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1)

Price

3290 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,125

SJR Impact factor

184

H Index

125

Total Docs (Last Year)

363

Total Docs (3 years)

5322

Total Refs

1577

Total Cites (3 years)

335

Citable Docs (3 years)

4.09

Cites/Doc (2 years)

42.58

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Pharmacokinetic Individualisation of Zidovudine Therapy

A Retrospective Analysis of Pharmacokinetic-Pharmacodynamic Parameters as Indicators of the Clinical Efficacy of Ceftizoxime

Pharmacokinetic Interactions of Antimalarial Agents

Population Pharmacokinetics of??Levetiracetam in Japanese and??Western Adults

Effect of Rifampicin on the Pharmacokinetics of Fluconazole in Patients with AIDS

Pharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux Disease

Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations

Pharmacokinetic Optimisation of Antibacterial Treatment in Patients with Cystic Fibrosis

Intracellular Concentrations of Antibacterial Agents and Related Clinical Implications

Pharmacokinetic Optimisation of Oral Antifungal Therapy

Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine

Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections

SHOW MORE ARTICLES

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

Application of a Gamma Model of Absorption to Oral Cyclosporin

Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

Evaluation of Pharmacokinetic Interactions After Oral Administration of Mycophenolate Mofetil and Valaciclovir or Aciclovir to Healthy Subjects

Relationship Between Minimum Inhibitory Concentration and Stationary Concentration Revisited

Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies

Authors' Reply to Coste et al.: "Levothyrox¬Æ New and Old Formulations: Are they Switchable for Millions of Patients?"

Osmotherapy for Elevated Intracranial Pressure

Dosage Adjustments for Antibacterials in Obese Patients

Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients

Comparative Pharmacokinetics and Pharmacodynamics of the Newer Fluoroquinolone Antibacterials